Table 2.
Clinical and laboratory findings on admission and in-hospital complications and procedures
| Hemodynamic data | |
| Systolic BP (mmHg) | 142.4±35 |
| Diastolic BP (mmHg) | 84.7±16.8 |
| Heart rate (bpm) | 87.1±21.8 |
| Laboratory findings | |
| Peak troponin I (µg/ml) | 3.16±4.5 |
| White blood count (×103/µl) | 9.61±4.82 |
| Creatinine (mg/dl) | 1.21±1,26 |
| Hemoglobin (g/dl) | 12.9±1.7 |
| ECG | |
| ST-segment elevation | 24 (43.6%) |
| QT interval (ms) | 376.5±52.4 |
| Echocardiography | |
| Mitral regurgitation Moderate to severe |
5 (9%) |
| Mild | 26 (47.3%) |
| LVOT gradient | 1 (1.8%) |
| Right ventricular involvement | 2 (3.6%) |
| LVEF (%) | 44.8±11.6 |
| Mid-apical involvement | 27 (56%) |
| Apical involvement | 20 (41.7%) |
| WMSI | 1.66±2.29 |
| PASP (mmHg) | 36.3±16.5 |
| In-hospital complications | 12 (21.8%) |
| Cardiogenic shock | 4 (7.2%) |
| Congestive heart failure | 3 (5.4%) |
| Intraventricular thrombus | 1 (1.8%) |
| Cerebral Ischemic lesion | 1 (1.8%) |
| Pulmonary artery systolic hypertension | 1 (1.8%) |
| Paroxysmal atrial fibrillation | 2 (3.6%) |
| In-hospital procedures | 3 (5.4%) |
| Stent implantation | 2 (3.6%) |
| CABG | 1 (1.8%) |
BP=blood pressure; LVOT=left ventricular outflow tract; LVEF=left ventricular ejection fraction; WMSI=wall motion score index; PASP=pulmonary artery systolic pressure; CABG=coronary artery bypass grafting.